Main > INFECTIOUS DISEASES > Virus Infectious Diseases+ > HIV Infection (AIDS) > Treatment > Co: UK. V. FosAmprenavir Ca



Co: UK. V. FosAmprenavir Ca's subsections
(*) EU Approval Date: 2004. 07.16.
(*) USA Approval Date: 2003. 10.20.
Company
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2006. 08.15.
Protease Inhibition
TradeMark (EU)
TradeMark (USA)
TradeMark (USA) Web-Site

Co: UK. V. FosAmprenavir Ca's products
This section has no products